- General information enquiries
- Call 00 800 6 7 8 9 10 11
- E-mail your questions

European Commission
Public Health
Accessibility tools
Service tools
Language selector
- Current languageen
Navigation path
- European Commission
- Public health
- Reference documents
- Register
- Orphan products
- Sodium benzoate
Pharmaceuticals - Community Register
Community register of orphan medicinal products | GRANTED |
Product information |
Sodium benzoate
| EU orphan designation number: | EU/3/16/1707
|
| Active ingredient: | Sodium benzoate |
| Indication: | Treatment of citrullinaemia type 1 |
| Sponsor: | Lucane Pharma SA
172 rue de Charonne, 75011 Paris, France |
Public summary of scientific opinion
European Commission procedures |
| Close date procedure | Procedure type | EMEA number | Decision | summary publ | decision docs | annex |
| 18/07/2016 | Orphan designation | EMA/OD/058/16 | (2016)4693 of 14/07/2016 |


